跳至主要内容
临床试验/EUCTR2004-004824-11-DE
EUCTR2004-004824-11-DE进行中(未招募)不适用

Role for pimecrolimus in restoring skin barrier function and normalizing epidermal lipid content and differentiation in atopic epidermis: a randomized, intra-patient, double-blind (right/left arm) study in adults with atopic dermatitis treated with 1% pimecrolimus cream and 0.1 % betamethasone cream as treatment control twice daily for 3 weeks - Pimecrolimus and Epidermal Barrier Function

niversitätshautklinik Kiel0 个研究点目标入组 15 人开始时间: 2005年10月4日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Adults with atopic dermatitis of mild to moderate severity.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients who are pregnant, nursing, immunocompromised or presenting signs of skin atrophy.

研究者

发起方
niversitätshautklinik Kiel

相似试验